Comments
Loading...

Relmada Therapeutics Stock Price, Quotes and Forecasts

RLMDNASDAQ
Logo brought to you by Benzinga Data
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Relmada Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:RLMD | Benzinga

Explore Relmada Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for RLMD.

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trends and Forecast
1
Sep 24
2
Dec 24
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.1
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell
Open-
Close-
Volume / Avg.5.01K / 1.44M
Day Range- - -
52 Wk Range0.24 - 6.63
Market Cap$8.14M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
29
Short Interest
5.89%
Days to Cover1
About Relmada Therapeutics Inc
Sector
Health Care
Industry
Pharmaceuticals
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chem...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
RLMD
CING

FAQ

Q

How do I buy Relmada Therapeutics (RLMD) stock?

A

You can purchase shares of Relmada Therapeutics (NASDAQ:RLMD) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Relmada Therapeutics (RLMD) competitors?

Q

What is the forecast, or price target, for Relmada Therapeutics (RLMD) stock?

A

Relmada Therapeutics has a consensus price target of $15.14.

Q

What is the current price for Relmada Therapeutics (RLMD)?

A

The stock price for Relmada Therapeutics (NASDAQ: RLMD) is $0.2698 last updated March 6, 2025 at 9:08 AM EST.

Q

Does Relmada Therapeutics (RLMD) pay a dividend?

A

There are no upcoming dividends for Relmada Therapeutics.

Q

When is Relmada Therapeutics (NASDAQ:RLMD) reporting earnings?

A

Relmada Therapeutics’s Q1 earnings are confirmed for Wednesday, May 7, 2025.

Q

Is Relmada Therapeutics (RLMD) going to split?

A

There is no upcoming split for Relmada Therapeutics.

Q

What sector and industry does Relmada Therapeutics (RLMD) operate in?

A

Relmada Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

People Also Watch